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The objective of this paper is to investigate whether Helicobacter pylori is an etiologic factor in hyperemesis gravidarum. Thirty one
patients with hyperemesis gravidarum and twenty nine pregnant controls without hyperemesis gravidarum were included in this
prospective study. All pregnant women were examined both for Helicobacter pylori serum immunoglobulin G antibodies (HpIgG
Ab), showing chronic infection, and Helicobacter pylori stool antigens (HpSA), showing active gastrointestinal colonization. Chi-
square and Student t tests were used accordingly for statistical analysis. Helicobacter pylori seropositivity was 67.7% in the patients
with hyperemesis gravidarum and 79.3% in the control group (χ2 = 1.02, P = .31). HpSA was detected in 22.6% of patients with
hyperemesis gravidarum, whereas 6.9% of patients in the control group. The diﬀerence was not statistically signiﬁcant (χ2 = 2.89,
P = .08). In this study, no relation was found between Helicobacter pylori and hyperemesis gravidarum. The low social status of
women in both groups could be one of the reasons for the high prevalence of Hp infection.
Copyright © 2006 R. Sinan Karadeniz et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
INTRODUCTION
Hyperemesis gravidarum (HG) is a common problem for an
obstetrician. Nausea and vomiting of pregnancy, commonly
known as “morning sickness,” aﬀects approximately 80% of
pregnant women and is generally a mild, self-limited condi-
tionthatmaybecontrolledwithconservativemeasures[1].A
small percentage, 1–2%, of pregnant women have a more se-
vere course, being HG. It is deﬁned as vomiting in pregnancy
which is pernicious to produce weight loss, dehydratation,
acidosis from starvation, alkalosis from loss of hydrochlo-
ric acid, and hypokalemia [2]. All these symptoms are not
absolutely necessary for the diagnosis. Mild to moderate ke-
tonuria may be seen in urine analysis [3]. The typical onset
is between 4 and 8 weeks’ gestation, continuing until 14–16
weeks of gestation [4]. Although several theories have been
proposed, the exact cause remains unclear. Several recent re-
searches have implicated the Helicobacter pylori (Hp) as one
possiblecause[4–7],whereastherewerealsofewrecentstud-
ies that could not determine any relation between Hp and
HG [8, 9]. So, the role of Hp in HG is controversial.
The purpose of this study is to investigate the possible as-
sociationbetweenHpinfectionandHGinagroupofTurkish
pregnant women in ﬁrst trimester.
MATERIALS AND METHODS
Thirty one (51.7%) subjects and 29 (48.3%) controls were
enrolled the study. Subjects were between 5 to 15 weeks’ ges-
tation and met the following criteria for hyperemesis gravi-
darum: severe vomiting (more than 3 times a day), weight
loss (more than 5% of body weight), and ketonuria. Patients
with known thyroid disease, multiple gestation, gestational
trophoblastic disease, psychological and gastrointestinal dis-
orders were excluded. Approval was obtained from the med-
ical ethical committee and informed consents were obtained.
Both groups were comparable for age, parity, and ultrasono-
graphical age. Twenty nine pregnant women without symp-
toms of nausea and vomiting were involved the study as con-
t r o lg r o u p .D e m o g r a p h i cd a t ao fb o t hg r o u p sw e r er e c o r d e d .
Gestational age was determined using the ﬁrst date of last
menstrual period and conﬁrmed by ultrasonography. The
participants eligible for the study had been informed about
thestudybeforebloodsamplesandstoolspecimenswerecol-
lected.
DeterminationofHpyloriIgGAntibody
Samples were obtained by venipuncture and centrifuged at
3000rpm for 10 minutes. Serum specimens were stored at2 Infectious Diseases in Obstetrics and Gynecology
Table 1: Demographic characteristics.
Characteristics Hyperemesis (n = 31) Control (n = 29) P
Age 25.83 ±4.68 26.27 ±5.95 NS
Gravidity 1.83 ±.89 2.86 ± 1.40 .001
Parity .64 ±.79 1.17 ± 1.03 NS
Gestational age (weeks) 9.63 ±2.39 11.80 ±2.70 .002
Ultrasonographic gestational age (weeks) 8.96 ±2.06 9.62 ± 2.43 NS
Table 2: Helicobacter pylori seropositivity and fecal antigen status in hyperemesis gravidarum.
Test Hyperemesis Control χ2 P
Positive Negative Positive Negative
HpIgG 21 (67.7%) 10 (32.3%) 23 (79.3%) 6 (20.7%) 1.02 .31
HpSA 7 (22.6%) 24 (77.4%) 2 (6.9%) 27 (93.1%) 2.89 .08
−30◦C until analysis. H pylori IgG antibody (HpIgG Ab)
was measured using enzyme-linked immunosorbent assay
(ELISA) kits (Virotech). Results were evaluated by BioTek
ELx 800 ELISA reader. Test results were reported as positive,
negative, and equivocal. The threshold value for a “positive”
result was accepted as ≥ 1.00 and ≤ .90 as a negative result.
Values between .91–.99 were interpreted as equivocal.
Determinationof HpyloriStoolAntigen
Stool samples from each patient were collected into clean
c u p sa n ds t o r e da t−30◦C until analysis. All samples were
tested for H pylori stool antigen (HpSA) using HpSA
enzyme-linked immunosorbent assay (Diagnostic BioProbes
srl, Milano, Italy) according to the manufacturers instruc-
tions. The cutoﬀ value for a positive result was considered as
≥ .298 at optical density of 450nm and <. 298 as a negative
result.
Statisticalanalysis
Statistical analysis was performed by using SPSS 10.0f o r
Windows (SPSS Inc, Chicago, Ill, USA) statistical software.
Comparison of serologic status of study and control groups
for HpIgG Ab and HpSA was assessed by chi-square test. De-
scriptivestatisticswereshownasarithmeticmean ±standard
deviation (SD). Student t test was used for comparing de-
m o g r a p h i c a lp r o p e r t i e so fg r o u p s .P value less than .05 was
considered as statistically signiﬁcant.
RESULTS
T h ea g e so ft h ew o m e ni nb o t hg r o u p sr a n g e df r o m1 7t o4 0
(mean26.05±5.29).Themeandurationofhospitalizationin
the study group was 3.22±.66 days. Both of the groups were
similar in respect to their age, parity, and ultrasonographic
age (Table 1).
The prevalence of HpIgG Ab was 67.7% (21 of 31) in the
patients with HG, and 79.3% (23 of 29) in controls (P = .31;
χ2 = 1.02). Positive HpSA was detected in 22.6% (7 of 31)
in the study group, and 6.9% (2 of 29) in the control group
(P = .08; χ2 = 2.89). There was no statistically signiﬁcant
diﬀerence in study and control groups for HpIgG Ab and
HpSA (Table 2). Although 67.7% of the patients with HG
had seropositivity, only 22.6% of them had an active gas-
trointestinal colonization. All of the patients who had HpSA
positive had positive IgG antibodies except one.
DISCUSSION
Helicobacter pylori, since its ﬁrst isolation in 1982 by Mar-
shall, represents one of the most common and medically
prominentinfectionsworldwide[10].Infectionwiththismi-
croaerobic, gram-negative bacterium has been established as
an etiologic factor in the development of peptic ulcer disease
andhasbeenassociatedwiththedevelopmentofgastricneo-
plasia [11]. Helicobacter pylori and its association with multi-
plegastroduodenaldiseaseshaveemphasizedtheimportance
ofdiagnosisofsymptomaticindividuals.Theproblemsindi-
agnosis are more complicated during pregnancy since HG
c a nm a s ka na c t i v eH pi n f e c t i o no rH Gm a yb es e v e r eb ys u -
perimposed Hp infection.
The causative relation between Hp and some other dis-
eases, beyond HG such as atherosclerosis, has been reported
recently. Results of the studies suggest that gastrointestinal
colonization of Hp increases atherosclerosis, formation of
atheroma, and ischemic heart disease [12–15]. Likewise, the
relationbetweenHpandHGhasbeenstudiedinrecentyears
[4,5,16].Althoughtheirﬁndingssuggestedapositiveassoci-
ationbetweenHGandHpseropositivity,somerecentstudies
c o u l dn o tﬁ n ds u c ha s s o c i a t i o n[ 8, 9]. Thus, this is one of the
controversial issues in obstetric care. It was obvious that fur-
ther studies were needed by tests other than serologic ones,
which were more sensitive and speciﬁc. To date, all the stud-
ies investigating a relation with Hp and HG were done byR. Sinan Karadeniz et al 3
serologic tests which can only be able to show chronic infec-
tions of Hp. Current study was planned for investigating the
association between Hp and HG by using both serologic and
stool antigen tests, the most recently developed test for Hp y -
lori in which the presence of the bacterium can be diagnosed
with a sample of stool.
Currently, several diagnostic strategies are available for
Hp infection. Serologic testing is a primary screening ap-
proach for evaluation of Hp status. The test shows IgG status
of patients infected with Hp. In one study, seroconversion to
IgG was demonstrated between 22 and 33 days after active
infection [17]. Although serologic testing had the lowest cost
per correct diagnosis, accuracy was lower than stool antigen
testing [18]. The HpSA-ELISA test determines the coloniza-
tion of H pylori in gastrointestinal tract by detecting Hp spe-
ciﬁc antigens in stool. Direct fecal antigen detection of Hp
has been approved by the US Food and Drug Administra-
tion for diagnosis and followup testing [11]. The sensitivity
and speciﬁcity of the HpSA test was found to be over 90%
in patients with gastroduodenal ulcer diagnosed by gastric
biopsy with rapid Hp urease test positivity. Vaira et al found
the HpSA test 94.1% sensitive and 91.8% speciﬁc [19].
In this study, we were unable to conﬁrm the reported
association between Hp and HG by both diagnostic meth-
ods. Frigo et al reported that 90.5 %o fw o m e nw i t hH Gw e r e
seropositive for Hp as compared to 46.5% of controls [4].
Another study from Turkey with HG found that 92% were
seropositive for Hp as compared to 45% of controls [5]. Al-
though these two European studies strongly suggested that
HG may be associated with Hp infection, two recent studies
foundnoassociationbetw eenHGandHpser o positi vity ,one
conductedintwoUSpopulationswithdisparateHpseropos-
itivity [8] and the other by Berker et al from Turkey [9].
In our study, seropositivity is high in both study and
control groups, 67.7% and 79.3%, respectively. One possi-
ble explanation to our result is the low socioeconomic level
of our patient population. Numerous epidemiologic studies
have shown that a major risk factor for Hp acquisition is low
socioeconomiclevelinbothdevelopinganddevelopedcoun-
tries [8, 20]. Our ﬁndings support this association. Although
serologic testing is the most common noninvasive diagnostic
method for Hp and is relatively inexpensive and convenient,
inouropinionatestthatshowsanactivegastrointestinalcol-
onization will be more appropriate in diagnosis of patients
with HG.
In summary, we were unable to ﬁnd an association be-
tween Hp and HG. The low social status of women in both
groups could be one of the reasons for the high prevalence of
Hp infection.
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